Helicobacter pylori roles in haematology disease pathogenesis
https://doi.org/10.18699/SSMJ20220302
Abstract
Helicobacter pylori is considered to be one of the significant reasons of formation of gastroduodenal pathology. Data on the role of H. pylori in the development of extragastric diseases are confirmed by a positive effect of eradication on peripheral blood changes. In spite of this fact both aspects are still not revealed. However, undoubtedly that H. pylori persistence on gastric epithelium creates conditions for chronic local and systematic inflammation. The aim of the sur- vey was the analysis of literary data about bacterial factors in the development of iron-, vitamin B12-deficiency anaemia and thrombocytopenic purpura included by the international consensus into the circle of evedences for diagnosis and treatment of H. pylori. Material and methods. There was accomplished search of literature sources with the help of data bases PubMed, CyberLeninka, eLibrary, Google Scholar. The results of our analysis specify mechanisms of cer- tain blood diseases pathogenesis in association with H. pylori. Multiple roles of virulent strains of pathogen in anaemia and thrombocytopenic purpura include: development of erosive and ulcerative lesions of mucosa, hypoacidity, chron- ic inflammation and autoimmune response. Data about these changes in haematological syndromes and independent eradication effects on blood parameters normalisation, are controversial. Н. pylori host iron competition theory has not been found convincing confirmation. Conclusions. It is necessary to study more deeply the connection of H. pylori and haematological diseases. The dietary research and application to maintain the mucous integrity and bacterial adhesion prevention are perspective.
About the Authors
M. V. Potapova
Saratov State Medical University n.a. V.I. Razumovsky of Minzdrav of Russia
Russian Federation
Russian Federation
Marina V. Potapova, candidate of medical sciences
410012, Saratov, Bolshaya Kazachya str., 112
N. A. Broyaka
Saratov State Medical University n.a. V.I. Razumovsky of Minzdrav of Russia
Russian Federation
Russian Federation
Nelli A. Broyaka, candidate of medical sciences
410012, Saratov, Bolshaya Kazachya str., 112
K. Yu. Skvortsov
Saratov Medical University «Reaviz»
Russian Federation
Russian Federation
Konstantin Yu. Skvortsov, candidate of medical sciences
410012, Saratov, Verkhniy Rynok, 10
E. V. Konobeeva
Saratov State Medical University n.a. V.I. Razumovsky of Minzdrav of Russia
Russian Federation
Russian Federation
Elena V. Konobeeva, candidate of medical science
410012, Saratov, Bolshaya Kazachya str., 112
References
1. Ivashkin V.T., Mayev I.V., Lapina T.L., Sheptulin A.A., Trukhmanov A.S., Baranskaya E.K., Abdulkhakov R.A., Alekseyeva O.P., Alekseyenko S.A., Dekhnich N.N., … Tsukanov V.V. Diagnostics and treatment of Helicobacter pylori infection in adults: Clinical guidelines of the Russian gastroenterological association. Rossiyskiy zhurnal gastroenterologii, gepatologii, koloproktologii = Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2018;28(1):55–70. [In Russian]. doi: 10.22416/1382-4376-2018-28-1-55-70
2. Smirnova O.V., Sinyakov A.A. Influence of Helicobacter pylori on cytokine regulation in chronic atrophic gastritis. Infektsiya i immunitet = Russian Journal of Infection and Immunity. 2020;10(1):18–192. [In Russian]. doi: 10.15789/2220-7619-IOH-1167
3. Öztekin M., Yılmaz B., Agagündüz D., Capasso R. Overview of Helicobacter pylori infection: clinical features, treatment and nutritional aspects. Diseases. 2021;9(4):66. doi: 10.3390/diseases9040066
4. Chmiela M., Gonciarz W. Molecular mimicry in Helicobacter pylori infections. World J. Gastroenterol. 2017;23(22):3964–3977. doi: 10.3748/wjg.v23. i22.3964
5. Campuzano-Maya G. Hematologic manifestations of Helicobacter pylori infection. World J. Gastroenterol. 2014;20(36):12818–12838. doi: 10.3748/wjg. v20.i36.12818
6. Mladenova I. Clinical relevance of Helicobacter pylori infection. J. Clin. Med. 2021;10:3473. doi: 10.3390/jcm10163473
7. Malfertheiner P., Megraud F., O’Morain C.A., Gisbert J.P., Kuipers E.J., Axon A.T., Bazzoli F., Gasbarrini A., Atherton J., Graham D.Y., ... European Helicobacter and Microbiota Study Group and Consensus panel. Management of Helicobacter pylori infection – the Maastricht V/ Florence Consensus Report. Gut. 2017;66:6–30. doi: 10.1136/gutjnl-2016-312288
8. Chey W.D., Leontiadis G.I., Howden C.W., Moss S.F. ACG Clinical Guideline: treatment of Helicobacter pylori infection. Am. J. Gastroenterol. 2017;112(2):212–239. doi: 10.1038/ajg.2016.563
9. Tsay F.W., Hsu P.I. H. pylori infection and extra-gastroduodenal diseases. J. Biomed. Sci. 2018;25(1):65. doi: 10.1186/s12929-018-0469-6
10. Tseng D.S., Li D., Cholleti S.M., Wei J.C., Jodesty Y., Pham H.V. Effect of Helicobacter pylori treatment on unexplained iron deficiency anemia. Perm. J. 2019;23:18–195. doi: 10.7812/TPP/18-195
11. Stasi R., Sarpatwari A., Segal J.B., Osborn J., Evangelista M.L., Cooper N., Provan D., Newland A., Amadori S., Bussel J.B. Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review. Blood. 2009;113:1231–1240. doi: 10.1182/ blood-2008-07-167155
12. Blecker U., Renders F., Lanciers S., Vandenplas Y. Syncopes leading to the diagnosis of a Helicobacter pylori positive chronic active haemorrhagic gastritis. Eur. J. Pediatr. 1991;150(8):560–561. doi: 10.1007/BF02072207
13. Rodriguez-Castro K.I., Franceschi M., Noto A., Miraglia C., Nouvenne A., Leandro G., Meschi T., de’ Angelis G.L., di Mario F. Clinical manifestations of chronic atrophic gastritis. Acta Biomed. 2018;89(8):88– 92. doi: 10.23750/abm.v89i8-S.7921
14. Emiralioglu N., Yenicesu I., Sari S., Egritas O., Poyraz A., Pasaoglu O.T., Celik B., Dalgic B. An insight into the relationships between prohepcidin, iron deficiency anemia, and interleukin-6 values in pediatric Helicobacter pylori gastritis. Eur. J. Pediatr. 2015;174(7):903–910. doi: 10.1007/s00431-014-2482-4
15. Haile K., Yemane T., Tesfaye G., Wolde D., Timerga A., Haile A. Anemia and its association with Helicobacter pylori infection among adult dyspeptic patients attending Wachemo University Nigist Eleni Mohammad Memorial Referral Hospital, Southwest Ethiopia: A cross-sectional study. PLoS One. 2021;16(1):e0245168. doi: 10.1371/journal. pone.0245168
16. Xu M.Y., Cao B., Yuan B.S., Yin J., Liu L., Lu Q.B. Association of anaemia with Helicobacter pylori infection: a retrospective study. Scientific Reports. 2017;7:13434. doi: 10.1038/s41598-017-13955-3
17. Hou B., Zhang M., Liu M., Dai W., Lin Y., Li Y., Gong M., Wang G. Association of active Helicobacter pylori infection and anemia in elderly males. BMC Infectious Diseases. 2019;19:228. doi: 10.1186/s12879019-3849-y
18. Franceschi F., Giupponi B., Ražuka-Ebela D. Helicobacter pylori and extragastric diseases. Helicobacter. 2018;23(1):e12520. doi: 10.1111/hel.12520
19. Hudak L., Jaraisy A., Haj S., Muhsen K. An updated systematic review and meta-analysis on the association between Helicobacter pylori infection and iron deficiency anemia. Helicobacter. 2017;22(1). doi: 10.1111/ hel.12330
20. Tan H.J., Goh K.L. Extragastrointestinal manifestations of Helicobacter pylori infection: facts or myth? A critical review. J. Dig. Dis. 2012;13:342–349. doi: 10.1111/j.1751-2980.2012.00599.x
21. Lee S.Y. Endoscopic gastritis, serum pepsinogen assay, and Helicobacter pylori infection. Korean J. Intern. Med. 2016;31:835–844. doi: 10.3904/ kjim.2016.166
22. Afanasenkova T.E., Golovanova E.D., Dubskaya E.E. Chronic Helicobacter pylori induced gastritis with erosive lesions of the gastric mucosa in the elderly. Eksperimental’naya i klinicheskaya gastroenterologiya = Experimental and Clinical Gastroenterology. 2019;(10):33–38. [In Russian]. doi:10.31146/1682-8658-ecg-170-10-33-38
23. Betesh A.L., Santa Ana C.A., Cole J.A., Fordtran J.S. Is achlorhydria a cause of iron deficiency anemia? Am. J. Clin. Nutr. 2015;102:9–19. doi. org/10.3945/ajcn.114.097394
24. Gravina A.G., Zagari R.M., de Musis C., Romano L., Loguercio C., Romano M. Helicobacter pylori and extragastric diseases: A review. World J. Gastroenterol. 2018;24(29):3204–3221. doi. org/10.3748/wjg. v24. i29.3204
25. Boyanova L. Role of Helicobacter pylori virulence factors for iron acquisition from gastric epithelial cells of the host and impact on bacterial colonization. Future Microbiol. 2011;6(8):843–846. doi: 10.2217/ fmb.11.75
26. Šterbenc A., Jarc E., Poljak M., Homan M. Helicobacter pylori virulence genes. World J. Gastroenterol. 2019;25(33):4870–4884. doi: 10.3748/wjg.v25. i33.4870
27. Scott C., Arora G., Dickson K., Lehmann C. Iron chelation in local infection. Molecules. 2021;26:189. doi.org/10.3390/ molecules26010189
28. Toyokuni S., Yanatori I., Kong Y., Zheng H., Motooka Y., Jiang L. Ferroptosis at the crossroads of infection, aging and cancer. Cancer Science. 2020;111:2665–2671. doi: 10.1111/cas.14496
29. Hamedi A.D., Farivar T.N., Rahmani B., Hajmanoochehri F., Razavi A.N., Jahanbin B., Dodaran M.S., Peymani A. The role of transferrin receptor in the Helicobacter pylori pathogenesis; L-ferritin as a novel marker for intestinal metaplasia. Microb. Pathog. 2019;126:157–164. doi: 10.1016/j.micpath.2018.10.039
30. Chmiela M., Kupcinskas J. Review: Pathogenesis of Helicobacter pylori infection. Helicobacter. 2019;24(1):e12638. doi: 10.1111/hel.12638
31. Worst D.J., Otto B.R., de Graaff J. Iron-repressible outer membrane proteins of Helicobacter pylori involved in heme uptake. Infect. Immun. 1995;63(10):4161–4165. doi: 10.1128/iai.63.10.41614165.1995
32. Isaeva G.Sh., Valieva R.I. Biological characteristics and virulence of Helicobacter pylori. Klinicheskaya mikrobiologiya i antimikrobnaya khimioterapiya = Clinical Microbiology and Antimicrobial Chemotherapy. 2018;20(1):14–23. [In Russian]. doi:10.36488/ cmac.2018.1.14-23
33. Olvera-Rosales L.B., Cruz-Guerrero A.E., Ramírez-Moreno E., Quintero-Lira A., ContrerasLópez E., Jaimez-Ordaz J., Castañeda-Ovando A., Añorve-Morga J., Calderón-Ramos Z.-G., Arias-Rico J. Impact of the gut microbiota balance on the health-disease relationship: the importance of consuming probiotics and prebiotics. Foods. 2021;10:1261. doi: 10.3390/ foods10061261
34. Yang J., Zhou X., Liu X., Ling Z., Ji F. Role of the gastric microbiome in gastric cancer: from carcinogenesis to treatment. Front. Microbiol. 2021;12:641322. doi: 10.3389/fmicb.2021.641322
35. Muhsen K., Cohen D. Helicobacter pylori infection and iron stores: a systemic review and metaanalysis. Helicobacter. 2008;13:323–340. doi:10.1111/ j.1523-5378.2008.00617.x
36. Andrews S.C., Robinson A.K., RodriguezQuinones F. Bacterial iron homeostasis. FEMS Microbio-logy Rev. 2003;27:215–237. doi: 10.1016/S01686445(03)00055-X
37. Briana R., Wilson L., Bogdan A.R., Miyazawa M., Hashimoto K., Tsuji Y. Siderophores in iron metabolism: from mechanism to therapy potential. Trends Mol. Med. 2016;22(12):1077–1090. doi:10.1016/j.molmed.2016.10.005
38. Kramer J., Özkaya Ö., Kümmerli R. Bacterial siderophores in community and host interactions. Nat. Rev. Microbiol. 2020;18(3):152–163. doi: 10.1038/ s41579-019-0284-4
39. Pozdeev O.K., Pozdeeva A.O., Valeeva Yu.V., Gulyaev P.E., Savinova A.N. Mechanisms of interaction of Helicobacter pylori with epithelium of gastric mucosa. I. Pathogenic factors promoting successful colonization. Infektsiya i immunitet = Russian Journal of Infection and Immunity. 2018;8(3):273–283. [In Russian]. doi:10.15789/2220-7619-2018-3-273-283
40. Johnstonea T.C., Nolan E.M. Beyond iron: nonclassical biological functions of bacterial siderophores. Dalton Trans. 2015;44(14):6320–6339. doi:10.1039/c4dt03559c
41. Qi B., Han M. Microbial siderophore enterobactin promotes mitochondrial iron uptake and development of the host via interaction with ATP synthase. Cell. 2018;175(2):571–582. doi: 10.1016/j.cell.2018.07.032
42. Yokota S., Toita N., Yamamoto S., Fujii N., Konno M. Positive relationship between a polymorphism in Helicobacter pylori neutrophil-activating protein a gene and iron-deficiency anemia. Helicobacter. 2013;18:112–116. doi:10.1111/hel.12011
43. Pich O.Q., Merrell D.S. The ferric uptake regulator of Helicobacter pylori: a critical player in the battle for iron and colonization of the stomach. Future Microbiol. 2013;8(6):725–738. doi: 10.2217/fmb.13.43
44. Flores S.E., Aitchison A., Day A.S., Keenan J.I. Helicobacter pylori infection perturbs iron homeostasis in gastric epithelial cells. PLoS One. 2017;12(9):e0184026. doi: 10.1371/journal. pone.0184026
45. Ellermann M., Arthur J.C. Siderophore-mediated iron acquisition and modulation of host-bacterial interactions. Free Radic. Biol. Med. 2017;105:68–78. doi: 10.1016/j.freeradbiomed.2016.10.489
46. Nairz M., Weiss G. Iron in infection and immunity. Mol. Aspects Med. 2020;75:100864. doi: 10.1016/j. mam.2020.100864
47. Weiss G., Ganz T., Goodnough L.T. Anemia of inflammation. Blood. 2019;33(1): 40–50. doi:10.1182/ blood-2018-06-856500
48. Pasini E., Corsetti G., Romano C., Aquilani R., Scarabelli T., Chen-Scarabelli C., Dioguardi F.S. Management of anaemia of chronic disease: beyond irononly supplementation. Nutrients. 2021;13:237. doi: 10.3390/nu 13010237
49. Madu A.J., Ughasoro M.D. Anaemia of chronic disease: an in-depth review. Med. Princ. Pract. 2017;26:1–9. doi: 10.1159/000452104
50. Jeyamani L., Jayarajan J., Leelakrishnan V., Swaminathan M. CagA and VacA genes of Helicobacter pylori and their clinical relevance. Indian J. Pathol. Microbiol. 2018;61(1):66–69. doi: 10.4103/IJPM. IJPM_234_17
51. Yang J.Y., Kim P., Jeong S.-H., Lee S.W., Myung Y.S., Baeg M.K., Kim J.B. The effects of sulglycotide on the adhesion and the inflammation of Helicobacter pylori. Int. J. Environ. Res. Public Health. 2020;17:2918. doi:10.3390/ijerph17082918
52. Hessey S.J., Spencer J., Wyatt J.I., Sobata G., Rathbone B.J., Axon A.T., Dixon M.F. Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis. Gut. 1990;31:134–138. doi: 10.1136/gut.31.2.134
53. Guruge J.L., Falk P.G., Lorenz R.G., Dans M., Wirth H.P., Blaser M.J., Berg D.E., Gordon J.I. Epithelial attachment alters the outcome of Helicobacter pylori infection. Proc. Nat. Acad. Sci. USA. 1998;95(7):3925–3930. doi: 10.1073/pnas.95.7.3925
54. Matsuo Y., Kido Y., Yamaoka Y. Helicobacter pylori outer membrane protein-related pathogenesis. Toxins (Basel). 2017;9:101. doi:10.3390/toxins9030101
55. Kato S., Osaki T., Kamiya S., Zhang X.S., Blaser M.J. Helicobacter pylori sabA gene is associated with iron deficiency anemia in childhood and adolescence. PLoS One. 2017;12:e0184046. doi:10.1371/journal.pone.0184046
56. Andersen L.P. Colonization and infection by Helicobacter pylori in humans. Helicobacter. 2007;12(2):12–15. doi: 10.1111/j.15235378.2007.00574.x
57. Cover T.L. Helicobacter pylori diversity and gastric cancer risk. mBio. 2016;7(1):e01869-15. doi: 10.1128/mBio.01869-15
58. Shcherbakov I.T., Leont’ieva N.I., Filippov V.S., Grachyova N.M., Solov’yova A.I., Vinogradov N.A. The morphology of the inflammation of the gastric and duodenal mucosa with Helicobacter pylori contamination. Morfologicheskie vedomosti = Morphological Newsletter. 2019;27(3):39–45. https://doi. org/10.20340/mv-mn.19(27).03.39-45
59. Pegasheva I.L., Pavlovich I.M., Gordienko A.V., Chyrskiy V.S., Erokhina A.A., Swarwal A.V. Influence of pathogenicity factors of Helicobacter pylori (Cag A and Vac A) on precancerous changes of gastric mucosa in patients with chronic gastritis. Eksperimental’naya i klinicheskaya gastroenterologiya = Experimental and Clinical Gastroenterology. 2019;(5):67–71. [In Russian]. doi: 10.31146/1682-8658-ecg-165-5-67-71
60. Vernigorodskiy S.V., Sukhan D.S. The role of the CagA gene in the occurrence of the inflammatory response of the gastric mucosa in patients with chronic Helicobacter pylori-associated gastritis. Reports of Morphology. 2018;24(3):11–18. doi: 10.31393/morphology-journal-2018-24(3)-02
61. Lahner E., Carabotti M., Annibale B. Treatment of Helicobacter pylori infection in atrophic gastritis. World J. Gastroenterol. 2018;24(22):2373–2380. doi: 10.3748/wjg.v24.i22.2373
62. Novikov V.V., Lapin V.A., Melent’ev D.A., Mokhonova E.V. Features of the human immune response to Helicobacter pylori infection. MediAl = MediAl. 2019;(2):55–69. [In Russian]. doi:10.21145/2225-0026-2019-2-55-69
63. Jackson S., Beck P.L., Pineo G.F., Poon M.C. Helicobacter pylori eradication: novel therapy for immune thrombocytopenic purpura? A review of the literature. Am. J. Hematol. 2005;78(2):142–150. doi: 10.1002/ajh.20250
64. Asahi M., Azuma T., Ito S., Ito Y., Suto H., Nagai Y., Tsubokawa M., Tohyama Y., Maeda S., Omata M., Suzuki T., Sasakawa C. Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells. J. Exp. Med. 2000;191:593–602. doi: 10.1084/ jem.191.4.593
65. Tummuru M.K., Sharma S.A., Blaser M.J. Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Mol. Microbiol. 1995;18:867– 876. doi: 10.1111/j.1365-2958.1995.18050867.x
66. Negovan A., Iancu M., Fülöp E., Bănescu C. Helicobacter pylori and cytokine gene variants as predictors of premalignant gastric lesions. World J. Gastroenterol. 2019;25(30):4105–4124. doi: 10.3748/wjg. v25.i30.4105
67. Mendoza E., Duque X., Franco J.I.F., Maldonado E.R., Morán S., Martínez G., Rodríguez A.R., Martínez H. Association between active H. pylori infection and iron deficiency assessed by serum hepcidin levels in school-age children. Nutrients. 2019;11:2141. doi:10.3390/nu11092141
68. O’Connor H.J., Axon A.T., Dixon M.F. Campylobacter-like organisms unusual in type A (pernicious anaemia) gastritis. Lancet. 1984;2:1091. doi: 10.1016/ s0140-6736(84)91523-x
69. Saito M., Mori A., Irie T., Tanaka M., Morioka M. Helicobacter pylori infection is not associated with pernicious anemia in Japan. Rinsho Ketsueki. 2008;49(11):1569–1571. [In Japanese].
70. Kokkola A., Kosunen T.U., Puolakkainen P., Sipponen P., Harkonen M., Laxen F., Virtamo J., Haapiainen R., Rautelin H. Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis. APMIS Journal of Pathology, Microbiology and Immulogy. 2003;111:619– 624. doi: 10.1034/j.1600-0463.2003.1110604.x
71. Rodriguez A.M., Urrea D.A., Prada C.F. Helicobacter pylori virulence factors: relationship between genetic variability and phylogeographic origin. PeerJ. 2021;9:e12272. doi: 10.7717/peerj.12272
72. Buerkli S., Ndiaye N.F., Cercamondi C.I., Herter-Aeberli I., Moretti D., Zimmermann M.B. Asymptomatic Helicobacter pylori infection in preschool children and young women does not predict iron bioavailability from iron-fortified foods. Nutrients. 2019;11:2093. doi:10.3390/nu11092093
73. Youssefi M., Tafaghodi M., Farsiani H., Ghazvini K., Keikha M. Helicobacter pylori infection and autoimmune diseases. Is there an association with systemic lupus erythematosus, rheumatoid arthritis, autoimmune atrophy gastritis and autoimmune pancreatitis? A systematic review and meta-analysis study. J. Microbiol. Immunol. Infect. 2021;54(3):359–369. doi: 10.1016/j. jmii.2020.08.011
74. Lenti M.V., Rugge M., Lahner E., Miceli E., Toh B.-H., Genta R.M., de Block C., Hershko C., di Sabatino F. Autoimmune gastritis. Nature Reviews Disease Primers. 2020;6(1):56. doi: 10.1038/ s41572-0200187-8
75. Johnson K.S., Ottemann K.M. Colonization, localization, and inflammation: the roles of H. pylori chemotaxis in vivo. Curr. Opin. Microbiol. 2018;41:51– 57. doi:10.1016/j.mib.2017.11.019
76. Sung J.J.Y., Coker O.O., Chu E., Szeto C.H., Luk S. T., Lau H.C.H., Yu J. Gastric microbes associated with gastric inflammation, atrophy and intestinal metaplasia 1 year after Helicobacter pylori eradication. Gut. 2020; 69:1572–1581. doi:10.1136/gutjnl-2019-319826
77. Kolmogorova T.O., Anchikova T.A. The role of Нelicobacter pylori in the development of small intestinal bacterial overgrowth syndrome. Dokazatel’naya gastroenterologiya = Russian Journal of Evidence-Based Gastroenterology. 2019;8(3):12–18. [In Russian]. doi:10.17116/dokgastro2019803112
78. Livzan M.A., Gaus O.V., Mozgovoy S.I. Chronic atrophic gastritis: patient management. RMJ. Meditsinskoe obozrenie = Russian Medical Inquiry. Medical Review 2021;5(6):427–432. [In Russian]. doi:10.32364/2587-6821-2021-5-6-427-432
79. Crafa P., Russo M., Miraglia C., Barchi A., Moccia F., Nouvenne A., Leandro G., Meschi T., De’Angelis G.L., Di Mario F. From Sidney to OLGA: an overview of atrophic gastritis. Acta Biomed. 2018;89(8):93–99. doi: 10.23750/abm.v89i8-S.7946
80. Lahner E., Marzinotto I., Lampasona V., Dottori L., Bazzigaluppi E., Brigatti C., Secchi M., Piemonti L., Conti L., Pilozzi E., … Annibale B. Autoantibodies toward ATP4A and ATP4B subunits of gastric proton pump H1,K1-ATPase are reliable serological pre-endoscopic markers of corpus atrophic gastritis. Clinical and Translational Gastroenterology. 2020;11(10):e00240. doi: 10.14309/ctg.0000000000000240
81. Rustgi S.D., Bijlani P., Shah S.C. Autoimmune gastritis, with or without pernicious anemia: epidemiology, risk factors, and clinical management. Ther. Adv. Gastroenterol. 2021;14:17562848211038771. doi: 10.1177/17562848211038771
82. Franceschi F., Annalisa T., Teresa D.T., Giovanna A., Ianiro G., Franco S., Viviana G., Valentina T., Riccardo L.L., Antonio G. Role of Helicobacter pylori infection on nutrition and metabolism. World J. Gastroenterol. 2014;20(36):12809–12817. doi: 10.3748/wjg. v20.i36.12809
83. Tsukanov V.V., Tonkikh Ju.L., Vasyutin A.V., Peretyatko O.V., Pulikov A.S., Baron I.I. astric mucosa structure in patients with different serum pepsinogen levels and ratios. Meditsinskiy sovet = Medical Council. 2018;(14):114–117. [In Russian]. doi:10.21518/2079-701X-2018-14-114-117
84. Vannella L., Lahner E., Osborn J., Annibale B. Systematic review: gastric cancer incidence in pernicious anaemia. Aliment. Pharmacol. Ther. 2013;37:375–382. doi: 10.1111/apt.12177
85. Lahner E., Persechino S., Annibale B. Micronutrients (Other than iron) and Helicobacter pylori infection: a systematic review. Helicobacter. 2012;17:1–15. doi: 10.1111/j.1523-5378.2011.00892.x
86. Maev I.V., Andreev D.N., Kucheryavyi Ju.A. Helicobacter pylori infection and extragastroduodenal diseases. Terapevticheskiy arkhiv = Therapeutic Archive. 2015;87(8):103–110. [In Russian]. doi:10.17116 /terarkh 2015878103-110
87. Asaturov A.V., Varzin S.A., Stroev Yu.I., Churilov L.P., Utekhin V.I. The role of autoimmune reactivity in pathogenesis of complicated forms of peptic ulcer disease in adults and children. Pediatr = Pediatrician. 2018;9(6):93–100. [In Russian]. doi:10.17816/PED9693-100
88. Terrell D.R., Beebe L.A., Neas B.R., Vesely S.K., Segal J.B., George J.N. Prevalence of primary immune thrombocytopenia in Oklahoma. Am. J. Hematol. 2012;87:848–852. doi: 10.1002/ajh.23262
89. Psaila B., Bussel J.B. Immune thrombocytopenic purpura. Hematol. Oncol. Clin. North. Am. 2007;21:743–759. doi: 10.1016/j.hoc.2007.06.007
90. Jang J.H., Kim J.Y., Mun Y.C., Bang S.M., Lim Y.J., Shin D.Y., Choi Y.B., Yhim H.Y., Lee J.W., Kook H., on the behalf of Korean Aplastic Anemia Working Party. Management of immune thrombocytopenia: Korean experts recommendation in 2017. Blood Res. 2017;52:254–263. doi: 10.5045/br.2017.52.4.254
91. Fan H., Zhu H.L., Li S.X., Lu X.C., Zhai B., Guo B., Yao S.Q., Liu Y. Efficacy of amifostine in treating patients with idiopathic thrombocytopenia purpura. Cell Biochem. Biophys. 2011;59:7–12. doi:10.1007/ s12013-010-9100-5
92. Zain M.A., Zafar F., Ashfaq A., Jamil A.R., Ahmad A. Helicobacter pylori: An underrated Cause of immune thrombocytopenic purpura. A comprehensive review. Cureus. 2019;11(9):e5551. doi:10.7759/ cureus.5551
93. Pezeshki S., Saki N., Ghandali M.V., Ekrami A., Avarvand A.Y. Effect of Helicobacter Pylori eradication on patients with ITP: a meta-analysis of studies conducted in the Middle East. Blood Res. 2021;56:38–43. doi: 10.5045/br.2021.2020189
94. Hwang J.J., Lee D.H., Yoon H., Shin C.M., Park Y.S., Kim N. The effects of Helicobacter pylori eradication therapy for chronic idiopathic thrombocytopenic purpura. Gut Liver. 2016;10(3):356–361. doi: 10.5009/gnl14483
95. Franchini M., Veneri D. Helicobacter pylori-associated immune thrombocytopenia. Platelets. 2006;17:71–77. doi: 10.1080/09537100500438057
96. Gasbarrini A., Franceschi F., Tartaglione R., Landolfi R., Pola P., Gasbarrini G. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet. 1998;352:878. doi: 10.1016/ S0140-6736(05)60004-9
97. Noonavath R.N., Lakshmi Ch.P., Dutta T.K., Kate V. Helicobacter pylori eradication in patients with chronic immune thrombocytopenic purpura. World J. Gastroenterol. 2014;20(22):6918–6923. doi:10.3748/ wjg.v20.i22.6918
98. Aljarad S., Alhamid A., Tarabishi A.S., Tarabishi A.S. # 2, Suliman A., Aljarad Z. The impact of Helicobacter pylori eradication on platelet counts of adult patients with idiopathic thrombocytopenic purpura. BMC Hematol. 2018;18:28. doi: 10.1186/s12878-0180119-y
99. Sheema K., Ikramdin U., Arshi N., Farah N., Imran S. Role of Helicobacter pylori eradication therapy on platelet recovery in chronic immune thrombocytopenic purpura. Gastroenterol. Res. Pract. 2017;2017:9529752. doi: 10.1155/2017/9529752
100. Jackson S., Beck P.L., Pineo G.F., Poon M.C. Helicobacter pylori eradication: novel therapy for immune thrombocytopenic purpura? A review of the literature. Am. J. Hematol. 2005;78:142–150. doi: 10.1002/ ajh.20250
101. Bettaieb A., Fromont P., Louache F., Oksenhendler E., Vainchenker W., Duédari N., Bierling P. Presence of cross-reactive antibody between human immunodeficiency virus (HIV) and platelet glycoproteins in HIV-related immune thrombocytopenic purpura. Blood. 1992;80(1):162–169.
102. Bettaieb A., Oksenhendler E., Duedari N., Bierling P. Cross-reactive antibodies between HIVgp120 and platelet gpIIIa (CD61) in HIV-related immune thrombocytopenic purpura. Clin. Exp. Immunol. 1996;103(1):19–23. doi: 10.1046/j.13652249.1996.917606.x
103. Kim B.J, Kim H.S., Jang H.J., Kim J.H. Helicobacter pylori eradication in idiopathic thrombocytopenic purpura: a meta-analysis of randomized trials. Gastroenterology Research and Practice. 2018;2018:6090878. doi: 10.1155/2018/6090878
104. Asahi A., Nishimoto T., Okazaki Y., Suzuki H., Masaoka T., Kawakami Y., Ikeda Y., Kuwana M. Helicobacter pylori eradication shifts monocyte Fcgamma receptor balance toward inhibitory FcgammaRIIB in immune thrombocytopenic purpura patients. J. Clin. Invest. 2008;118(8):2939–2949. doi: 10.1172/JCI34496
105. Yamanishi S., Iizumi T., Watanabe E., Shimizu M., Kamiya S., Nagata K., Kumagai Y., Fukunaga Y., Takahashi H. Implications for induction of autoimmunity via activation of B-1 cells by Helicobacter pylori urease. Infect. Immun. 2006;74(1):248–256. doi: 10.1128/IAI.74.1.248-256.2006
106. Rahman Y.A., Wahid Ahmed L.A., Hafez R.M., Ahmed R.M.M. Helicobacter pylori and its hematological effect. The Egyptian Journal of Internal Medicine. 2019;31:332–342. doi: 10.4103/ejim.ejim_103_18
107. Byrne M.F., Kerrigan S.W., Corcoran P.A., Atherton J.C., Murray F.E., Fitzgerald D.J., Cox D.M. Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation. Gastroenterology. 2003;124(7):1846–1854. doi: 10.1016/ s0016-5085(03)00397-4
108. Scopel-Guerra A., Olivera-Severo D., Staniscuaski F., Uberti A.F., Callai-Silva N., Jaeger N., Porto B.N., Carlini C.R. The impact of Helicobacter pylori urease upon platelets and consequent contributions to inflammation. Front. Microbiol. 2017;8:2447. doi: 10.3389/fmicb.2017.02447
109. Appelmelk B.J., van Die I., van Vliet S.J., Vandenbroucke-Grauls C.M., Geijtenbeek T.B., van Kooyk Y. Cutting edge: carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells. J. Immunol. 2003;170(4):1635–1639. doi: 10.4049/jimmunol.170.4.1635
110. Voland P., Hafsi N., Zeitner M., Laforsch S., Wagner H., Prinz C. Antigenic properties of HpaA and Omp18, two outer membrane proteins of Helicobacter pylori. Infect. Immun. 2003;71(7):3837–3843. doi:10.1128/IAI.71.7.3837-3843.2003
111. Holland R.L., Bosi K.D., Harpring G.H., Luo J., Wallig M., Phillips H., Blanke S.R. Chronic in vivo exposure to Helicobacter pylori VacA: Assessing the efficacy of automated and long-term intragastric toxin infusion. Sci. Rep. 2020;10:9307. doi: 10.1038/ s41598-020-65787-3
112. Satoh K., Hirayama T., Takano K., SuzukiInoue K., Sato T., Ohta M., Nakagomi J., Ozaki Y. VacA, the vacuolating cytotoxin of Helicobacter pylori, binds to multimerin 1 on human platelets. Thromb. J. 2013;11:23. doi: 10.1186/1477-9560-11-23
113. Frydman G.H., Davis N., Beck P.L., Fox J.G. Helicobacter pylori eradication in patients with immune thrombocytopenic ourpura: a review and the role of biogeography. Helicobacter. 2015;20:239–251. doi: 10.1111/hel.12200
114. Veneri D., de Matteis G., Solero P., Federici F., Zanuso C., Guizzardi E., Arena S., Gaio M., Pontiero P., Ricetti M.M., Franchini M. Analysis of Band Tcell clonality and HLA class II alleles in patients with idiopathic thrombocytopenic purpura: correlation with Helicobacter pylori infection and response to eradication treatment. Platelets. 2005;16:307–311. doi: 10.1080/09537100400028685
115. Sugano K., Tack J., Kuipers E.J., Graham D.Y., El-Omar E.M., Miura S., Haruma K., Asaka M., Uemura N., Malfertheineret P., faculty members of Kyoto Global Consensus Conference. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015; 64:1353–1367. doi:10.1136/gutjnl-2015-309252
116. Neunert C., Terrell D.R., Arnold D.M., Buchanan G., Cines D.B., Cooper N., Cuker A., Despotovic J.M., George J.N., Grace R.F., … Vesely S.K. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3:3829– 3866. doi: 10.1182/bloodadvances.2019000966
117. Fock K.M., Katelaris P., Sugano K., Ang T.L., Hunt R., Talley N.J., Lam S.K., Xiao S.D., Tan H.J., Wu C.Y., … Second Asia-Pacific Conference. Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J. Gastroenterol. Hepatol. 2009;24:1587– 1600. doi: 10.1111/j.1440-1746.2009.05982.x
118. Masataka K. Helicobacter pylori-associated immune thrombocytopenia: clinical features and pathogenic mechanisms. World J. Gastroenterol. 2014;20(3):714–723. doi: 10.3748/wjg.v20.i3.714
119. Kuwana M. Helicobacter pylori-associated immune thrombocytopenia: clinical features and pathogenic mechanisms. World J. Gastroenterol. 2014;20:714–723. doi: 10.3748/wjg.v20.i3.714
120. National Society of Hematology, National Society of Pediatric Hematologists and Oncologists. Clinical guidelines. Iron-deficiency anemia. Available at: https://npngo.ru/uploads/media_document/636/161b822ae1f6-4c71-a39b-975866e61ff8.docx [In Russian].
121. National Hematological Society, National Society of Pediatric Hematologists, Oncologists. Clinical guidelines. Vitamin B12 deficiency anemia. Available at: https://npngo.ru/uploads/media_document/634/bb602760-b006-4983-a56e-c3bc333b6151.docx [In Russian].
122. National Hematological Society. Clinical guidelines. Idiopathic thrombocytopenic purpura (ITP) in adults. Available at: https://npngo.ru/uploads/media_document/631/4a7a26c4-0f1b-4588-b2db-4b99d54d72e5.pdf [In Russian].
Review
For citations:
Potapova M.V., Broyaka N.A., Skvortsov K.Yu., Konobeeva E.V. Helicobacter pylori roles in haematology disease pathogenesis. Сибирский научный медицинский журнал. 2022;42(3):18-35. (In Russ.) https://doi.org/10.18699/SSMJ20220302
Views:
652
Email this article 